Innate Pharma

是其中之一......

• CAC All-Trade;
• TOB Iconic 10,000.

Innate Pharma 是一家在股票代码 IPH (FR) 下上市的公司。

查看带有其 20 名主要高管的组织结构图

Innate Pharma 搜索最多的简介

• Jonathan Dickinson, Chief Executive Officer and Chairman of the Bo...
• Irina Staatz-Granzer, Chairman of the Board
• Gilles Brisson, Member of the Supervisory Board

高管在Innate Pharma变化

• Jonathan DickinsonJonathan Dickinson 将于202411月1作为 Chief Executive Officer and Chairman of the Board 加入公司  (新闻发布的2024十月14号).
• Herve Brailly 曾任 Interim Chief Executive Officer, 现任 Advisor  (新闻发布的2024十月14号).

创建提醒
跟踪 Innate Pharma 的高管变动

Innate Pharma 拥有 1,831 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。

Popular M&A news in 药店

• Stemtech and Seacret Direct have announced they will merge  (公布2024十二月5号)..
• Recursion Pharma and Exscientia have merged  (公布2024十一月27号)..
• Stemtech and Seacret Direct have announced they will merge  (公布2024十一月22号)..

药店 行业的其他推荐联系人

• Adare Pharmaceuticals 企业 Kristin Berkinsky - Chief Human Resources Officer
• Sanofi 企业 Julie Van Ongevalle - Executive Vice President and Head of Consumer Healthcare
• Amneal Pharmaceuticals 企业 Paul Meister - Chairman of the Board

了解更多有关药店行业的信息 >

Innate Pharma 的最新新闻稿

• Innate Pharma highlights abstracts selected for the ASH annual meeting 2024 | Innate Pharma
• Innate Pharma and the Institute for Follicular Lymphoma Innovation (IFLI) announce up to $7.9m investment from IFLI to support IPH6501 development in Follicular Lymphoma | Innate Pharma
• Innate Pharma presents lacutamab improved health-related quality of life data at ASH 2024 from TELLOMAK Phase 2 study in patients with cutaneous T cell lymphoma | Innate Pharma
• Innate Pharma announces publication in Science Immunology highlighting innovative next-generation ANKET® IPH6501 | Innate Pharma
• All press releases | Innate Pharma
• Innate Pharma releases its 2025 financial calendar | Innate Pharma
• Innate Pharma reports Third Quarter 2024 Business Update and Financial Results | Innate Pharma
• Innate Pharma announces conference call and webcast for third quarter 2024 results and business updates | Innate Pharma
• Innate Pharma highlights data from its innovative oncology portfolio selected for the SITC Annual Meeting 2024 | Innate Pharma
• Innate Pharma announces its participation in upcoming investor conferences | Innate Pharma
• View more press releases Close

关于 Innate Pharma 的社交媒体

• Innate Pharma 在 维基百科、谷歌新闻 和 雅虎财经
• Innate Pharma 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Jonathan Dickinson

致电Innate Pharma，电话：+33 43...

查看组织结构图

Register to receive your alert

报告错误